Concourse Financial Group Securities, Inc. Verona Pharma PLC Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share
Q4 2024 Feb 13, 2025	BUY	$28.71 - $47.02 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$15.46 - $30.16 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$11.48 - $17.02 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$15.3 - $20.24 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$11.94 - $20.47 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$16.3 - $22.09 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$16.3 - $22.09 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$19.41 - $23.43 $0 - $0
Q1 2023 May 15, 2023	BUY	$18.06 - $25.27 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$9.84 - $26.13 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$4.14 - $13.59 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$3.55 - $5.06 $0 - $0
Q1 2022 May 09, 2022	BUY	$4.82 - $6.98 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$3.91 - $7.08 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$5.29 - $6.35 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$5.72 - $9.09 $0 - $0
Q1 2021 May 13, 2021	BUY	$7.08 - $9.33 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$5.51 - $8.11 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$4.45 - $10.2 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$3.6 - $6.12 $0 - $0
Q1 2020 May 13, 2020	BUY	$2.16 - $7.28 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$3.7 - $6.58 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$4.03 - $5.44 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$5.1 - $6.91 $0 - $0
Q1 2019 May 15, 2019	BUY	$5.52 - $10.0 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$9.0 - $13.47 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$11.65 - $14.1 $0 - $0

Others Institutions Holding VRNA

# of Institutions

217

Shares Held

70.5M

Call Options Held

1.4M

Put Options Held

299K

Perceptive Advisors LLC New York, NY

6.39M
Shares

$411 Million
9.9% of portfolio
Nea Management Company, LLC Timonium, MD

5.58M
Shares

$359 Million
18.53% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.38M
Shares

$217 Million
9.42% of portfolio
Eventide Asset Management, LLC Boston, MA

3.13M
Shares

$201 Million
2.79% of portfolio
Lee Ainslie Maverick Capital LTD | Dallas, Tx

3.13M
Shares

$201 Million
2.81% of portfolio

View Full List

About Verona Pharma plc

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $3.92B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

More about VRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account